Results
1 -
10 of
11
(Click
here to explore results)
New Horizons in Predictive Drug Metabolism and Pharmacokinetics, CHAPTER 9 Chemically Reactive Versus Stable Drug Metabolites: Role in Adverse Drug Reactions . Thomas A. Baillie
, 2016
, Pages 202-226
New Tools to Interrogate Endocannabinoid Signalling: From Natural Compounds to Synthetic Drugs, Chapter 5 Natural and Synthetic Cannabinoids Targeting Non-CB1 , Non-CB2 G Protein-coupled Receptors . Paula Morales, Israa H. Isawi, Patricia H. Reggio
, 2021
, Pages 168-200
Synthetic Methods in Drug Discovery: Volume 2, Chapter 14 Asymmetric Methods and Their Use in the Pharmaceutical Industry . Peter D. Smith, Mark A. Graham, Rachel H. Munday, Craig S. Donald, Thomas M. McGuire, Robert E. Kyne Jr.
, 2016
, Volume 2
, Pages 139-262
New Horizons in Predictive Drug Metabolism and Pharmacokinetics, Contents
, 2016
, Pages P013-P021
New Tools to Interrogate Endocannabinoid Signalling: From Natural Compounds to Synthetic Drugs, Chapter 3 Natural Compounds and Synthetic Drugs to Target Type-1 Cannabinoid (CB1 ) Receptor . Christos Iliopoulos-Tsoutsouvas, Markos-Orestis Georgiadis, Lipin Ji, Spyros P. Nikas, Alexandros Makriyannis
, 2021
, Pages 48-88
Chirality from Dynamic Kinetic Resolution, Chapter 2 Chiral Catalysts
, 2011
, Pages 49-143
Pharmaceutical Process Development: Current Chemical and Engineering Challenges, Chapter 11 Development Enabling Technologies . Mike J. Monteith, Mark B. Mitchell
, 2011
, Pages 238-259
Extracellular and Intracellular Signaling, Chapter 11 G Protein-Coupled Receptors: Conformational “Gatekeepers” of Transmembrane Signal Transduction and Diversification . Ravinder Abrol, William A. Goddard III, FRSC
, 2011
, Pages 188-229
New Horizons in Predictive Drug Metabolism and Pharmacokinetics, Subject Index
, 2016
, Pages 414-422
Synthetic Methods in Drug Discovery: Volume 2, Subject Index
, 2016
, Volume 2
, Pages 505-517